InvestorsHub Logo
icon url

Joe Stocks

11/01/02 10:09 AM

#40680 RE: Joe Stocks #40678

>>>In Wednesday's market monitor at OptionInvestor.com we mentioned
that there was some trader talk that Teva Pharmaceutical
(NASDAQ:TEVA) $77.43 might be added to the NASDAQ-100. This
proves true as the Israeli generic drug maker will join the
NASDAQ-100 Index (NDX.X) effective at the beginning of trading
November 7, replacing Concord EFS (NASDAQ:CEFT) $14.28, which is
moving its listing to the NYSE. Salomon Smith Barney expects
indexers to sell a total of 21.5 million CEFT shares and purchase
3.4 million TEVA shares.


icon url

sylvester80

11/01/02 10:16 AM

#40687 RE: Joe Stocks #40678

Who's Ronald Baron?